Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 686 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
17 Мб
Скачать
CHAPTER 13 Nervous and Locomotor Systems
s
)
Transcellular Receptor mediated transcytosis, e.g. insulin
Transcellular A e.g. albumin
261
• CSF ows from the lateral ventricles to the third ven­tricle via the interventricular foramina; it then ows to the fourth ventricle via the cerebral aqueduct. From the fourth ventricle CSF ows into the subarachnoid space via the foramen of Luschka (lateral) and the foramen of Magendie (midline).
• e CSF circulates around the subarachnoid space and is reabsorbed back into the circulation via the arachnoid villi; these drain into the venous sinuses.
• e arachnoid villi may become blocked by blood fol­lowing a subarachnoid haemorrhage and prevent reab­sorption of CSF; this results in hydrocephalus.
Capillary
Tight junction
• A small amount of CSF is also absorbed by spinal villi in the lumbar region.
• CSF has two main functions:
• hydraulic ‘cushion’: serves to protect the brain from
violent movements of the head
• provides a stable ionic environment for cerebral
function.
Blood–Brain Barrier (Fig. 13.2)
• Lipid-soluble molecules are able to pass freely from the blood into the interstitial space of the brain; however, ions are unable to pass freely into the brain. is enables
Astrocyte foot proces
lumen
Basement membrane
Fig. 13.2 The blood–brain barrier. (A) Longitudinal section through a capillary in the brain. The capillaries
have tight cell-to-cell junctions and the astrocytes project foot processes to cover the capillary basement membrane. (B) Transverse section through a capillary in the brain, showing methods of transport across the blood–brain barrier.
A
dsorptive transcytosis,
B
Astrocyte foot process
Capillary
lumen
Tight junction
Lipid soluble transport, e.g. CO2, O2, alcohol, anaesthetic agents
Basement membrane
Carriers (transport proteins e.g. glucose, amino acids
262
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
the brain to maintain the ionic environment within very tight limits, thus allowing the optimal environment for neuronal communication.
• e blood–brain barrier also prevents the release of neurotransmitters from neurons into the peripheral circulation.
• e blood–brain barrier is formed by the structure of the capillaries. Rather than the freely permeable fenes­trated capillaries found in other tissues, the cerebral capillaries have very tight cell-to-cell junctions in the endothelium. In addition, the end-feet of astrocytes cover the basement membrane.
• Specic functions provided by the blood–brain barrier are:
• tight junctions restrict penetration of water-soluble
substances
• lipid-soluble molecules such as CO2, O2, hormones,
anaesthetics and alcohol (that’s why we get drunk!) can pass freely across the barrier via the lipid mem­branes of the capillary endothelium
• the endothelium contains transport proteins (carri-
ers) for nutrients such as sugars and amino acids
• certain proteins, e.g. insulin and albumin, may be
transported by endocytosis and transcytosis
• an ‘eux pump’ extrudes unwanted lipid soluble
molecules back into the blood.
• e blood–brain barrier is not continuous and in some areas consists of fenestrated capillaries. ese areas lie in the midline and include:
• third and fourth ventricles: allow drugs and noxious
chemicals to trigger the chemoreceptor area in the oor of the fourth ventricle; this in turn triggers the vomiting centre. In addition angiotensin II passes to the vasomotor centre in this region to increase sympathetic outow and causes vasoconstriction of peripheral vessels
• posterior lobe of pituitary: allows the release of oxy-
tocin and antidiuretic hormone (ADH) into the circulation
• hypothalamus: this allows the release of releasing or
inhibitory hormones into the portal–hypophyseal tract.
BRAINSTEM DEATH
• e brainstem provides the capacity for consciousness.
• e cerebral hemispheres provide the content of consciousness.
• Brainstem death is a condition in which the heart and lungs function, but there is no cerebral activity.
• It is legally regarded as being equivalent to the more tra­ditional mode of death, i.e. cessation of respiratory and cardiac activity.
• e diagnosis of brainstem death is important for several reasons:
• withdrawal of treatment
• assessment for suitability for organ donation.
• e diagnosis of brainstem death must rst satisfy sev­eral preconditions and exclusions before the appropriate tests can be performed.
Preconditions for the Diagnosis of Brainstem Death
• ere are four preconditions:
• the patient must be in a coma
• there must be a known cause for the patient’s coma
• this cause must be known to be irreversible
• the patient must be dependent on a ventilator.
Exclusion Criteria for the Diagnosis of Brainstem Death
• ere are a number of exclusion criteria:
• no residual drug eects from narcotics, hypnotics, tran-
quillizers, muscle relaxants, alcohol and illicit drugs
• core body temperature must be >35°C
• no circulatory, metabolic or endocrine abnormality
disturbance that may contribute to the coma.
Brainstem Death Tests
• e UK brainstem death criteria tests seven areas. All must be absent for the diagnosis to be made.
• e tests include:
1. No pupillary response to light, direct or consensual:
this reex involves cranial nerves II and III.
2. Absent corneal reex – normally would result in
blinking; this reex involves cranial nerves V and VII.
3. No motor response in the cranial nerve distribution
to stimuli in any somatic area, e.g. supraorbital or nailbed pressure leading to a grimace.
4. No gag reex: back of the throat is stimulated with a
catheter; this reex tests cranial nerves IX and X.
5. No cough reex: no response to bronchial stimula-
tion with a suction catheter; this reex tests cranial nerves IX and X.
6. No vestibulo-ocular reex: head is exed to 30° and
50 mL of ice-cold water is injected over 1 min into each external auditory meatus; there should be no eye movements; this reex tests cranial nerves III, VI and VIII.
7. Apnoea test: the patient is preoxygenated with 100%
O2 for 10 min; PaCO2 is allowed to rise to 5 kPa (before testing); the patient is disconnected from the ventilator and O2 is insuated at 6 L/min; PaCO2 is allowed to rise to 6.5kPa; there should be NO respi­ratory eort.
CHAPTER 13 Nervous and Locomotor Systems
Decompensation
Intracranial pressure (ICP; mmHg)
Intracranial volume (arbitrary units)
• ere are several other caveats to the brainstem death tests:
• performed on two occasions
• performed by two doctors
• one must be a consultant
• must be competent in the eld, e.g. ITU or neurology
• must have >5 years’ experience
• must not be part of the transplant team.
• e time of death is legally dened as the time at which the rst set of brainstem tests were performed.
263
Herniation
100
80
60
40
SPACE-OCCUPYING LESIONS AND RAISED INTRACRANIAL PRESSURE
• Space-occupying lesions (SOLs) result from a variety of causes, and may be focal or diuse.
• Focal SOLs include:
• tumour
• aneurysm
• blood or haematoma
• granuloma
• tuberculoma
• cyst
• abscess.
• Diuse SOLs result from either vasodilatation or oedema.
• e consequences of intracranial SOLs include:
• raised intracranial pressure
• intracranial shi and herniation
• hydrocephalus.
Raised Intracranial Pressure (ICP) (Fig. 13.3)
• e skull is a rigid container in which brain, CSF and blood are the only contents; it therefore follows that ICP = V
• is formula is the basis for the Monro–Kellie hypoth­esis, which states that the ICP will increase if the volume of one component is increased; the increase in ICP can only be compensated for by a decrease in one or both of the other components.
• Normal ICP in the supine position is 0–10 mmHg.
• e removal of blood and CSF can accommodate a SOL of approximately 100–150 mL; aer this compensatory point the ICP will increase rapidly.
• Raised ICP has a number of consequences:
• hydrocephalus: an increase in ICP may result in
the interruption of CSF ow; this is most com­monly seen with posterior fossa lesions leading to compression of the cerebral aqueduct and fourth ventricle
• cerebral ischaemia: remember that CPP=MAP −
ICP. Any rise in ICP will eventually exceed autoregu­lation and lead to cerebral ischaemia
CSF
+ V
Brain
+ V
Blood
20
0
Fig. 13.3 Pressure–volume curve for intracranial
pressure (ICP). The compensatory properties of the intracranial contents follow a pressure–volume expo­nential curve. Increased volume of any of the three components (i.e. brain, CSF, blood) can be accom­modated up to a certain point without any change in intracranial pressure. Once a critical volume is reached, decompensation occurs, i.e. blood and CSF have been pushed from the cranial cavity and ICP increases exponentially to the point of herniation.
• brain shi and herniation: as ICP increases the risk of herniation increases; this occurs at specic sites (Fig. 13.4):
• transtentorial: the lesion lies within one hemi-
sphere; leads to herniation of the medial part of the temporal lobe over the tentorium cerebelli
• tonsillar: caused by a lesion in the posterior fossa;
.
the lowest part of the cerebellum pushes down into the foramen magnum and compresses the medulla
• subfalcial: caused by a lesion in one hemisphere;
leads to the herniation of the cingulate gyrus under the falx cerebri
• diencephalic: generalized brain swelling; leads to
the midbrain herniating through the tentorium; this is termed coning
• systemic eects: the systemic eects of raised ICP are thought to occur due to autonomic imbalance, hypothalamic overactivity (due to compression) and ischaemia of the vasomotor area; the eects include:
• Cushing’s response: respiratory rate, bradycar-
dia and hypertension
• neurogenic pulmonary oedema
• Cushing’s ulcers
• preterminal events include bilateral pupil con-
striction followed by dilation, tachycardia, respiratory rate, and hypotension.
264
Parahippocampal
Cingulate
f
foramen magnum
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
Lateral
ventricle
gyrus
Skull
Dura
Tentorium
cerebelli
Midbrain
Pons
Cerebellum
gyrus
Medulla
Falx cerebri
Sub-falcine
herniation
Expanding lesion
Collapse o ventricle
Transtentorial herniation
Cerebellar tonsil herniation into
Fig. 13.4 Diagram illustrating the possible consequences of an expanding lesion, i.e. haematoma, on one side
of the brain. Diencephalic herniation is caused by generalized brain swelling.
• e clinical manifestations of raised ICP include:
• e clinical manifestations of cerebral herniation include:
• headache
• nausea and vomiting
• papilloedema
• decreased conscious level.
• oculomotor nerve compression: ipsilateral pupil dilation (transtentorial)
• cerebral peduncles: contralateral hemiparesis (transtentorial)
• posterior cerebral artery: cortical blindness (transtentorial)
• cerebral aqueduct: hydrocephalus (transtentorial)
• compression of cardio/respiratory centres in the medulla: death (tonsillar)
• reticular activating system: coma (all types)
• anterior cerebral artery: infarction (subfalcial)
• distortion of the midbrain and tearing of vessels: death (all types).
• e symptoms can include:
• clouding of consciousness
• restlessness
• abnormalities of perception
• incoherent speech
• agitation
• violence
• pulling out lines, catheters, drains, etc.
• ere are numerous factors that predispose to or cause post-operative confusion; these include:
• dehydration
• electrolyte abnormalities
• hypoxia
• infection
• drugs
• uraemia
• hypoglycaemia
• pre-existing psychiatric disorder or dementia
• alcohol and drug withdrawal (particularly in young
patients)
Post-Operative Confusion
• One of the commonest complications occurring in elderly patients.
• urinary retention
• pain and anxiety
• cerebrovascular accident (CVA)
CHAPTER 13 Nervous and Locomotor Systems
membrane
Membrane potential (mV)
stimulus
Time (ms)
Membrane permeability
265
• head injury (especially in trauma patients)
• sleep deprivation
• ITU syndrome: pain, fear and sleep deprivation can lead to visual and auditory hallucinations and inabil­ity to dierentiate reality from fantasy.
• Post-operative confusion is an important complication with many serious underlying causes; a full manage­ment plan must be formulated and the cause sought. Appropriate management should include:
• history and examination
• FBC, U&E, LFT, glucose, ABG
• ECG
• sepsis screen: blood cultures, chest X-ray, sputum,
midstream urine, wound swab.
• If a specic cause is found then this must be corrected, e.g. hypoxia, urinary retention; however, non-specic treatment may include:
• eliminate drugs likely to cause or increase the confu-
sional state
• presence of nursing sta in a well-lit environment
• low-dose sedation, e.g. haloperidol
• physical restraint – only if patient at risk of harming
self or others.
PERIPHERAL NERVOUS SYSTEM (PNS)
Conduction and Transmission
Action Potentials (Fig. 13.5)
• Action potentials are the method by which nerves send information; they are electrical signals and are described as ‘all-or-nothing’.
• Axons have a resting membrane potential with respect to the extracellular environment; this is approximately 70 mV.
• As stimuli attempt to activate an action potential the membrane potential is decreased towards a ‘threshold’; stimuli below this threshold will not result in an action potential and are described as subthreshold. If the stim­ulus is large enough to decrease the membrane poten­tial above the threshold then this will result in an action potential.
• e action potential, once initiated, begins with a rapid depolarization and a reversal of the membrane poten­tial to around 50 mV; this occurs in a few tenths of a millisecond.
• Following depolarization is repolarization: this is where the cell returns to the normal resting membrane poten­tial; the repolarization may initially be more negative than the resting potential – hyperpolarization.
• During the action potential the cell has an ‘absolute’ refractory period in which no further action potential can be generated. During repolarization then a ‘rela­tive’ refractory period exists; an action potential can be stimulated but will need a stimulus of greater magni­tude than the initial stimulus.
• Action potentials self-propagate: once the cell is stimu­lated, the signal will propagate along all cells.
• e intra- and extracellular concentrations of Na+ and K+ dier:
• Na+ concentration is greater extracellularly and thus
tends to diuse into the cell, both along this concen­tration gradient and due to the negative membrane potential
• K+ has a greater concentration intracellularly and
thus tends to diuse out of the cell.
• e change in permeability of the cell to Na+ and K+ during an action potential is due to conformational changes in voltage-controlled ion channels by the initial stimulus depolarizing the cell membrane.
Fig. 13.5 (A) Graph illustrating the theory of the ‘all-or-nothing’ response to electrical stimuli. (B) The ion
flows responsible for depolarization and repolarization of a nerve. (From McGeown JG. Physiology, 2nd edn. Churchill Livingstone, Edinburgh, 2002, with permission.)
+50
Depolarisation
0
–70
Subthreshold
stimulus
A
0
Suprathreshold
5
Repolarisation
Threshold
Time (ms)
Resting
potential
Na
or conductance (arbitrary units)
0
B
0
Depolarisation
K
24
Repolarisation
266
Action potential jumps from node to node
Myelin sheath
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
• e initial depolarization is due to the rapid inux of Na+ as the Na+ channel opens; at the same time the K+ channel also opens and K+ is released into the extracel­lular environment.
• e Na+ channel activates much faster than the K+ channel. is explains the rapid inux of Na+; the chan­nel also closes much faster; the K+ channel remains open over a longer period than the Na+ channel and is responsible for repolarization as K+ is released and the membrane potential falls back to its negative value.
Propagation of Action Potentials
• e action potential results in the inside of the cell being positive in respect to the extracellular environment; this is the opposite of the normal negative resting membrane potential; as a result, the action potential travels from positive to negative.
• e action potential is unidirectional and sets up local currents that result in the propagation of the action potential across the whole membrane; the action poten­tial is unidirectional due to the refractory nature of the membrane, preventing further depolarization.
• e conduction velocity of action potentials is deter­mined by two factors:
• axon diameter: the greater the diameter the higher
the conduction velocity; this eect is due to the
increase in myelin causing a decrease in electrical resistance
• myelination: myelinated cells have a much faster conduction velocity in comparison with unmyelin­ated cells (50–100 m/s vs 1 m/s); this eect is due to the gaps between the myelin sheath that surrounds nerves. ese gaps are called the nodes of Ranvier. Action potentials are generated only at these points as the myelin acts to insulate the intervening sec­tions; thus, the action potential jumps between the gaps. is is referred to as saltatory conduction (Fig. 13.6).
A classication of nerve bres is shown in Table 13.1.
Synaptic Transmission
• When an action potential reaches the end of an axon it must be transmitted to the next adjacent nerve; the gap between neurons is known as the synapse.
• Transmission of the signal relies on the release of neu­rotransmitters; these then aect the adjacent nerve chemically to initiate another action potential.
• e action potential travels along the presynaptic nerve. e axon terminates in an expanded end; this is called the terminal bouton.
• Inside the bouton are numerous membrane-bound ves­icles containing neurotransmitters.
Axon
Node of Ranvier
Transverse
section
Schwann cell
Schwann cell membrane
forms myelin sheath
Axon
Fig. 13.6 Action potential conduction in a myelinated nerve fibre (saltatory conduction). (From McGeown JG.
Physiology, 2nd edn. Churchill Livingstone, Edinburgh, 2002, with permission.)
nucleus
Axon membrane
CHAPTER 13 Nervous and Locomotor Systems
267
TABLE 13.1 Different Types of Nerve
Fibre, Showing Functions, Conduction Velocities and Diameters
Conduction
Type Function
Aα
Aβ
Aγ
Aδ
B Autonomic 10 3
C Pain 1 0.5–1
Motor
proprioception
Touch and
pressure
Muscle spindles 30 3–6
Pain,
temperature and touch
Velocity (m/s)
100 15–20
50 5–10
20 2–5
Diameter (µm)
• e transmission of the action potential occurs by:
• the action potential depolarizes the presynaptic membrane by opening voltage-gated Ca2+ channels
• Ca2+ enters the axon down an electrochemical and concentration gradient
• the increase in Ca2+ results in the vesicles fusing with the presynaptic membrane and releasing neu­rotransmitters into the synaptic cle
• the neurotransmitters then bind with receptors on the post-synaptic membrane
• binding of neurotransmitters initiates secondary signals within the cell and opens ion channels, thus generating a depolarizing current
• the transmitter is released from the receptor and is broken down by specic breakdown pathways.
Neurotransmitters
• Neurotransmitters are chemicals that are responsible for the transmission of action potentials across the synapse.
• e main neurotransmitters include:
• acetylcholine (ACh): this is an excitatory transmit-
ter; it is present in the brain, spinal cord, autonomic nerves and the PNS. It is broken down to acetate and choline by the enzyme acetylcholinesterase
• amines: this group includes catecholamines (adrena-
line, noradrenaline, and dopamine), 5-hydroxytrypta­mine (serotonin) and histamine. e catecholamines are formed from the amino acid tyrosine. Two enzymes degrade catecholamines: monoamine oxi­dase breaks down transmitter taken up by the pre­synaptic neuron; and catechol-O-methyl transferase breaks down catecholamines taken up by the postsyn­aptic neuron
• amino acids: several amino acids act as neurotrans­mitters; these include:
• glycine: inhibitory
• glutamate: excitatory or inhibitory (can be con-
verted to GABA)
• aspartate: excitatory
• peptides: examples of peptide transmitters include:
• substance P: involved in the transmission of pain
sensation
• endorphins: inhibit pain pathways.
Pain and Sensation
• Pain is dened as an unpleasant sensory and emotional experience associated with actual or potential tissue damage.
• Pain can be classied into:
• nociceptive: somatic and visceral
• referred
• neuropathic
• psychogenic.
• Nociceptive and referred pain are the commonest types of pain encountered in the surgical patient.
• Somatic pain is dened as pain that originates from the skin, muscles, bones and joints; it tends to be sharp in nature and is well localized.
• Visceral pain is due to ischaemia, inammation and stretching or contraction (colic) of smooth muscle in hollow viscera; it is poorly localized.
• Referred pain occurs when damage to an internal organ is associated with pain in a particular skin region; this occurs as the organ in question shares the same derma­tomal innervation as the region the pain is felt. Examples of referred pain include:
• MI and angina: pain may be referred to the neck, jaw,
shoulder and le arm
• spleen: haemoperitoneum leads to le-sided diaphrag-
matic irritation and le shoulder tip pain (Kehr’s sign)
• appendix: central abdominal pain in the T10 der-
matome is the initial sign until peritoneal irritation localizes the pain to the right iliac fossa
• gall bladder: cholecystitis can lead to irritation of the
right hemidiaphragm and right shoulder tip pain (Boas’ sign).
• Pain can also be classied according to the speed of onset; so-tissue injury is associated with a sudden sharp pain that lasts for a few seconds and is followed by a longer-lasting dull throbbing pain. Peripheral nerves dier in their diameter and conduction velocity; this explains the dierent pain sensations:
• Aδ bres: these are myelinated nerves; as a result,
they have a high conduction speed and diameter. ey are responsible for the sharp initial pain
268
Descending inputs
Pons
brain
afferent
= Opioid receptors
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
Periaqueductal
grey matter
and
raphe magnus
mid-
Nucleus
Serotonin
+
Enkephalin-releasing hormone
Locus
coeruleus
-
Noradrenaline
(Norepinephrine)
Relay neurone
Fig. 13.7 Descending inputs modulating pain sensation.
• C bres: these are unmyelinated nerves and thus have a smaller diameter and lower conduction veloc­ity. ey are responsible for the longer-lasting dull pain.
• Pain transmission can be divided into:
• transduction
• transmission
• modulation
• perception.
• Transduction involves the production of electrical impulses; following tissue damage there is the release of inammatory substances, i.e. prostaglandins, hista­mine, serotonin, bradykinin and substance P. ese sub­stances lead to electrical impulses that are transmitted along sensory nerves.
• Transmission of pain sensation is along Aδ and C bres to the spinal cord; here they synapse in lamina I and III in the dorsal horn.
• e sensation of pain is then transmitted along the spi­nal cord where it is modulated before nally being per­ceived in the sensory areas of the brain.
• Modulation of pain involves the ‘gate control theory’ of Melzack and Wall: this theory proposes that pain impulses received in the dorsal horn can be modulated by other descending spinal inputs. ese include inhibi­tory inputs from the periaqueductal grey matter and nucleus raphe magnus (both releasing serotonin) and
-
Pain sensation
º
I neuron
the locus coeruleus (releases noradrenaline) (Fig. 13.7). In addition there is the release of the naturally occurring enkephalins and endorphins.
Drug Modulation of Pain
• ere are numerous forms of analgesia used in current surgical practice; each acts on dierent elements in the chain of pain sensation.
• e provision of analgesia is particularly useful in the sur­gical patient; the eects of inadequate analgesia include:
• respiratory:
chest wall splinting
tidal volume
vital capacity
functional residual capacity (FRC)
• diculty coughing and retention of secretions, leading to atelectasis and pneumonia
• cardiovascular:
• pain increases BP and heart rate, thus placing increased strain on the heart
• immobilization and increased risk of thromboembolism
• ileus
• urinary retention
• stress response
• psychological stress.
• Transduction: drugs like paracetamol and NSAIDs inhibit prostaglandin production. Prostaglandins are
CHAPTER 13 Nervous and Locomotor Systems
269
involved in sensitizing nociceptive receptors in injured tissues to the eects of nociceptive compounds such as bradykinin and substance P.
• Transmission: Aδ and C bres are involved in the trans­mission of pain sensation. Local anaesthetics can be used to prevent the conduction of action potentials in these nerve bres. Aβ bres are involved in inhibiting transmission to higher centres; stimulation can thus provide analgesia. is is the basis for TENS (transcu­taneous electrical nerve stimulator) machines.
• Modulation: opioids are potent analgesics. ey pro­duce their eect by combining with opioid receptors in the spinal cord and higher centres. e analgesic eect of opioids is due to:
• combining with receptors in higher centres such as
the periaqueductal grey matter and nucleus raphe magnus; here they stimulate descending inhibitory inputs to pain perception
• binding to opioid receptors in the dorsal horn and
inhibiting pain transmission; this action is believed to be related to hyperpolarizing the cell and thus decreasing the chance of propagating the pain impulse
• inhibiting the release of substance P.
• Perception: pain perception can be inuenced by factors such as fear, anxiety, depression, and activation of the ‘ght or ight’ mechanism.
AUTONOMIC NERVOUS SYSTEM (ANS) (Fig. 13.8)
• e autonomic nervous system is involved in the control of visceral organs, smooth muscle and secretory glands.
• It is principally involved in maintaining the internal environment by regulating cardiac, respiratory and digestive functions.
• e eerent neurons of the ANS have a two-neuron arrangement. is diers from somatic nerves. e cell body of the rst neuron lies in the brainstem or spinal cord (preganglionic); the second neuron is located in the periphery in an autonomic ganglion (post-ganglionic).
• e ANS can be divided into two specic functional groups:
• sympathetic
• parasympathetic.
Sympathetic Nervous System
• Sympathetic neurons:
• located in the thoracic and upper 2–3 lumbar seg-
ments of the spinal cord
• preganglionic neurons lie in the lateral horn of the
spinal grey matter
• preganglionic axons leave via the ventral root of the spine to join the spinal nerve (see Chapter 4)
• post-ganglionic neurons have their cell bodies either in the sympathetic chain (see Chapter 4) or in a named plexus along the aorta, i.e. coeliac, superior and inferior mesenteric.
• Spinal nerves are connected to the sympathetic chain by two small branches: the lateral white ramus communi­cantes (myelinated), and the medial grey ramus com-
• e sympathetic innervation of the head and neck is via preganglionic neurons synapsing with post-ganglionic bodies within the sympathetic chain; the post-ganglionic neurons then leave via the grey rami communicantes to join the spinal nerve.
• e sympathetic innervation of the abdominal and pelvic organs diers from that of the head and neck. Preganglionic neurons pass straight through the sym­pathetic chain to their individual plexuses and synapse with post-ganglionic cell bodies within the plexus.
• e neurotransmitter of the sympathetic nervous sys­tem is noradrenaline (except sweat glands; these are innervated by cholinergic bres).
Parasympathetic Nervous System
• Preganglionic neurons lie in cranial nerve nuclei within the brainstem; the parasympathetic output is derived from the oculomotor, facial, glossopharyngeal and vagus nerves; this provides innervation to the head, neck, thorax and abdomen.
• e pelvic viscera are innervated by preganglionic neu­rons derived from the S2–4 spinal roots.
• e parasympathetic nervous system feeds into ve ganglia before being distributed to the structures it innervates; these ganglia are:
• oculomotor (III) nerve ciliary ganglion
• facial (VI) nerve sphenopalatine ganglion and
submandibular ganglion
• glossopharyngeal (IX) nerve otic ganglion
• S2–4 → pelvic splanchnic nerve → pelvic ganglion.
• e cell bodies of post-ganglionic neurons lie in gan­glia that are found in close proximity to the organ they innervate; an example would be the enteric nervous system (see Chapter 10). Here neurons contribute to two plexuses, the myenteric and submucosal. ese are found within the bowel wall itself.
• e neurotransmitter of the parasympathetic nervous system is acetylcholine.
Functions of the Autonomic Nervous System
• e eects of the autonomic nervous system are sum­marized below.
270
Spinal
Spinal
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
cord
A
SECTION II Physiology
Sympathetic chain
Superior cervical ganglion
Cervicothoracic ganglion
Coeliac
ganglion
Renal
ganglion
Pelvic ganglion
Head and neck
Dilator pupillae Blood vessels Sweat glands Muscles of hairs
Respiratory tract Cardiac branches Oesophagus
Gut from stomach to colon
Liver, biliary tract Pancreas
Kidney, ureter
Bladder Hind gut
Reproductive tract
Ciliary muscle
Sphincter pupillae
Lacrimal gland
Nasal glands
Submandibular gland
Sublingual gland
Parotid gland
Oesophagus
Cardiac branches
Respiratory tract
Gut from stomach
to colon
Liver, biliary system
Pancreas
Bladder
Urethra
Hind gut
Uterus, uterine tubes
Erectile tissue
B
1
Oculomotor nerve
2
3
pharyngeal
Glosso
4
Pelvic splanchnic
5
Facial nerve
nerve
Vagus nerve
nerve
cord
S2 S3 S4
Fig. 13.8 (A) Layout of the sympathetic nervous system. (B) The parasympathetic nervous system: 1 = ciliary
ganglion, 2 = sphenopalative ganglion, 3 = submandibular ganglion, 4 = otic ganglion, 5 = pelvic ganglion.
• Sympathetic system:
• dilates pupils
• reduces salivary secretions
• reduces lacrimal secretions
• increases heart rate (tachycardia)
• increases the contractility of the heart
• bronchodilation
• decreases GI motility
• increases sweat gland secretion
• contraction of erector pili muscles in the skin.
• Parasympathetic system:
• constricts pupils
• increases salivary secretion
• increases lacrimal secretion
• decreases heart rate (bradycardia)
• decreases the contractility of the heart
• bronchoconstriction
• increases GI motility.
LOCOMOTOR SYSTEM
Skeletal Muscle Physiology
Structure of Skeletal Muscle
• Muscles are composed of a number of muscle bres; these are grouped together to form bundles called fasciculi.
• e muscle bres are composed of numerous lamen­tous bundles called myobrils.
• e myobrils contain the contractile proteins actin and myosin; under a microscope muscle has a striated appearance due to the arrangement of actin and myosin:
• the dark bands or A bands are composed of the
thicker myosin laments
• the light bands or I bands are composed of the thin-
ner actin laments
• the I band is divided by the Z line; the space between
Z lines is called a sarcomere